Company: SONM
Filing Date: 2025-08-08
Form Type: 10-Q
Source: 0001641172-25-022821
Chunk: 14

Company: SONIM TECHNOLOGIES INC
Filing Date: 2025-08-08
Form: 10-Q
Item: Item 8
Chunk 14
---
 June 30, 2025. The following table sets
forth total interest expense recognized related to the Note:

 Schedule of Interest Expense

    Three Months
 Ended June 30, 2025  
    Six Months
 Ended June 30, 2025 
  
    Contractual interest expense 
    $76  
    $106 
  
    Amortization of debt discount 
     45  
     64 
  
    Amortization of debt issuance costs 
     40  
     62 
  
    Interest expense 
    $161  
    $232 

Subsequent
to June 30, 2025, the Company entered into an additional note purchase agreement. See Note 11, Subsequent Events.

NOTE
5 — Stockholders’ Equity

Equity
Financing

On
April 29, 2024, the Company closed on a capital investment of 350,000 shares of common stock and warrants, as adjusted for the Reverse
Stock Split, with a single investor for an aggregate purchase price of $3,850. In connection with the closing, the Company incurred approximately
$66 in issuance costs, which was offset against the proceeds.

Each
warrant has an exercise price of $11.00 per share, as adjusted for the Reverse Stock Split, is immediately exercisable, will expire in
five years from the date of issuance, and is subject to customary adjustments for certain transactions affecting the Company’s
capitalization. The warrants may not be exercised if the aggregate number of shares of common stock beneficially owned by the investor
subsequent to the exercise exceeds the specified beneficial ownership limitation provided therein (which is currently 9.99% and may be
adjusted upon advance notice).

On
May 12, 2025, the Company closed on a capital investment of 1,100,000 shares of common stock and 550,000 warrants with two investors
for an aggregate purchase price of $1,375. In connection with the closing, the Company incurred approximately $169 in issuance costs,
which was offset against the proceeds.

Each
warrant has an exercise price of $1.3864 per share, is immediately exercisable, will expire in five years from the date of issuance,
and is subject to customary adjustments for certain transactions affecting the Company’s capitalization. The warrants may not be
exercised if the aggregate number of shares of common stock beneficially owned by the investor subsequent to the exercise exceeds the
specified beneficial